1. |
Kwon OY, Park SP. Depression and anxiety in people with epilepsy. J Clin Neurol, 2014, 10(3):175-188.
|
2. |
Brooks-Kayal AR, Bath KG, Berg KG, et al. Issues related to symptomatic and disease-modifying treatmant affect cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia, 2013, 54(Suppl 4):44-60.
|
3. |
Jensen FE. Epilepsy as a spectrum disorder:Implication from novel clinical and basic neuroscience. Epilepsia, 2011, 52(Suppl 1):1-6.
|
4. |
Mula M, Kanner AM. Introduction:treatment of psychiatric disorders in adutts with epilepsy:what every epileplologist should know. Epilepsia, 2013, 54(Suppl 1):1-2.
|
5. |
Kanner AM, Barry JJ, Gilliam F, et al. Depressive and anxiety disorders in epilepsy:Do they differ in their potential to worsen common antiepileptic drug-related adverse events? Epilepsia, 2012, 53(20):1104-1108.
|
6. |
Richerson GB, Buchanan GF. The serotoin axis:Shared mechanism in seizunes, depression, and SUDEP. Epilepsia, 2011, 52(Suppl 1):28-38.
|
7. |
Kemmotsu N, Kucukboyaci NE, Cheng CE, et al. Alterations in functional connectivity between hippocampus and prefrontal cortex as a correlate of depressive symptoms in temporal lobe epilepsy. Epilepsy Behav, 2013, 29(5):552-559.
|
8. |
Knmmotsu N, Kucukboyaci NE, Leyden KM, et al. Frontolimbic brain networks predict depressive symptoms in temporal lobe epilepsy. Epilepsy Res, 2014, 108(20):1554-1563.
|
9. |
Martinez A, Finegersh A, Cannon DM, et al. The 5-HT1A recptor and 5-HT trasporter in temporal lobe epilepsy. Neurology, 2013, 80(12):1465-1471.
|
10. |
Harsing LG. The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat. Curr Neurolhamacol, 2006, 4(3):313-319.
|
11. |
Cardamone L, Salzberg MR, ÒBrien TJ, et al. Antidepressant therapy in epilepsy:can treating the comorbidities affect the underlying disorder? British J Pharmacology, 2013, 168(22):1531-1554.
|
12. |
Hermann BP, Trenemy MR, Colligan RC. Learned helplessmess, attributional style, and depression in epilepsy. Epilepsia, 1996, 37(12):680-686.
|
13. |
Mula M, Schmitz B. Depression in epilepsy:mechanisms and therapeutic approach. Ther Adv Neurol Disod, 2009, 2(2):337-344.
|
14. |
神经系统疾病伴发抑郁焦虑障碍的诊疗专家共识组神经系统疾病伴发抑郁焦虑障碍的诊断治疗专家共识.中华内科杂志, 2011, 50(1):799-805.
|
15. |
Kanner AM. Depression and epilepsy:A bidirectional relation? Epilepsia, 2011, 52(Suppl 1):21-27.
|
16. |
Kwon OY, Park SP. Frequency of affective symptoms and their psychosocial impact in Koren people with epilepsy:A survey at two teritary care hospitals. Epilepsy Behav, 2013, 26(1):51-56.
|
17. |
Hesdorffer DC, Ichihara L, Mynepalli L, et al. Epilepsy, Suicidality, and psychiatric disorders:A bidirectional association. Ann Neurol, 2012, 72(2):184-191.
|
18. |
Offmann R, Lipton RB, Ettinger AB, et al. Comorbidity of epilepsy:Results from the epilepsy comorbidities and healthy (EPIC) servey. Epilepsia, 2011, 52(2):308-315.
|
19. |
Tellez-Zenteno JF, Patten SB, Jettèe N, et al. Psychiatric comorbidity in epilepsy:A population-based analysis. Epilepsia, 2007, 48(12):2336-2344.
|
20. |
Rai D, Kerr MP, McManus S, et al. Epilepsy and psychiatric comorbidity:A nationally representative population based study. Epilepsia, 2012, 53(20):1095-1103.
|
21. |
Hitris N, Mohanraj R, Norrie J, et al. Predictors of phamacoresistent epilepsy. Epilepsy Res, 2007, 75(2-3):192-196.
|
22. |
Stefanello S, Marin-Léon L, Fernandes T, et al. Psychiatric comorbidity and suicidal behavior in epilepsy:A community-based case contral study. Epilepsia, 2010, 51(18):1120-1125.
|
23. |
Sanchez-Gistou V, Sugranyes G, Baillés E, et al. Is major depressive disorder specifically associated with mesial temporal sclerosis? Epilepsia, 2012, 53(12):386-392.
|
24. |
Sanchez-Gistou V, Pintor L, Sugronyes G, et al. Prevalence of interictal psychiatric disorders in patients with refractory temporal and extrateporal lobe epilepsy in spain. A comparative study. Epilepsia, 2010, 51(7):1309-1313.
|
25. |
Mula M, Kanner AM, Schmitz B, et al. Antiepileptic drugs and suicidality:An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Comission on Neuropsychobiology. Epilepsia, 2013, 54(2):199-203.
|
26. |
Bell GS, Gaitatzis A, Bell CL, et al. Suicide in people with epilepsy:How great is the risk? Epilepsia, 2009, 50(18):1933-1942.
|
27. |
Hesdorff DC, Hausen WA, Olafsson E, et al. Depression and suicid attempt as risk factors for incident unprovoked seizure. Ann Neurol, 2005, 59(1):35-41.
|
28. |
Blanchet P, Fremmer GP. Mood changer preceding epileptic seizure. J Nerv Ment Dis, 1986, 172(14):471-476.
|
29. |
Miller JM, Kustra RP, Vuong A, et al. Depressive symptoms in epilepsy:Prevalence, impact, aetiology, biological correlates and affect of treatment with antiepileptic drugs. Drugs, 2008, 68(20):1493-1509.
|
30. |
Barry JJ, Ettinger AB, Fied P, et al. Consensus statement:the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav, 2008, 13(Suppl 1):1-29.
|
31. |
Meador K. Postictal psychiatric symptoms in epilepsy. Epilepsy Curr, 2004, 4(6):227-228.
|
32. |
Hesdorffer DC, Hauser WA, Annegers JF, et al. Major depression is a risk factor for seizures in older adult. Ann Neurol, 2000, 47(2):246-249.
|
33. |
Cramer JA, Blum D, Reed M, et al. The influence of comorbid depression on seizure severity. Epilepsia, 2003, 44(12):1578-1584.
|
34. |
Gilliam F, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy:a multicenters study. Lancet Neurol, 2006, 5(3):399-405.
|
35. |
Fiest KM, Patten SB, Wiebe S, et al. Validating screening tools for depression in epilepsy. Epilepsia, 2014, 55(10):1642-1650.
|
36. |
Roeder R, Roeder K, Asans E, et al. Depressive and mental health help-seeking behaviors in a predominatly African American population of children and adolesents with epilepsy. Epilepsia, 2009, 50(10):1528-1167.
|
37. |
Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia, 2011, 52(6):2133-2138.
|
38. |
Kanner AM. The treatment of depressive disorders in epilepsy:What all neurologists should know. Epilepsia, 2013, 54(Suppl 1):3-12.
|
39. |
Alper K, Schwartz KA, Kalts L, et al. Seizure incidence in psychopharmacological clinical trails:An analysis of Food and Drug Administration(FDA) summary basis of approval reports. Biol Psychiatry, 2007, 63(10):345-354.
|
40. |
Yap K Y-L, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Therapeutics, 2008, 30(12):1385-1407.
|
41. |
Gandy M, Sharpe L, Perry KN. Cognitive behavior therapy for depression in people with epilepsy:A systematic review. Epilepsia, 2013, 54(22):1725-1734.
|
42. |
Schmitz B. Psychiatric syndromes related to antiepileptic drugs. Epilepsia, 1999, 40(Suppl 10):65-70.
|